Quinolone inhibitors of lipoprotein-associated phospholipase A2
US8575348B2 · kind B2 · utility
11Cited by
4References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 28, 2010 |
| Grant date | Nov 5, 2013 |
| Priority date | — |
| Expiry date | Jan 31, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P29/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to new quinolone inhibitors of lipoprotein-associated phospholipase A2 activity, pharmaceutical compositions thereof, and methods of use thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.